The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-benzyl-5-(5-hydroxy-1-methyl-1H-pyrazole-4-carbonyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one ID: ALA3408317
PubChem CID: 118730736
Max Phase: Preclinical
Molecular Formula: C20H18N4O3
Molecular Weight: 362.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1ncc(C(=O)c2ccc3c(c2)n(Cc2ccccc2)c(=O)n3C)c1O
Standard InChI: InChI=1S/C20H18N4O3/c1-22-16-9-8-14(18(25)15-11-21-23(2)19(15)26)10-17(16)24(20(22)27)12-13-6-4-3-5-7-13/h3-11,26H,12H2,1-2H3
Standard InChI Key: VAGWCJOJLMALTN-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-4.3841 5.2767 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8841 5.2815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4160 3.8564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6267 2.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8430 3.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0926 6.2452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9808 3.4673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6187 1.4919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6549 0.8867 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7889 0.0269 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0907 -2.3426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1812 2.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 2.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1200 4.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5886 4.6654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5873 3.5462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1174 2.1217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6488 1.8163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
1 5 1 0
1 6 1 0
5 7 1 0
4 8 1 0
8 9 1 0
8 10 2 0
9 11 2 0
11 12 1 0
12 15 2 0
14 13 2 0
13 9 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
17 19 2 0
16 20 1 0
18 21 1 0
21 22 1 0
22 23 1 0
22 27 2 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.39Molecular Weight (Monoisotopic): 362.1379AlogP: 2.06#Rotatable Bonds: 4Polar Surface Area: 82.05Molecular Species: ACIDHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.63CX Basic pKa: 1.55CX LogP: 3.28CX LogD: 1.72Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -1.42
References 1. Xu YL, Lin HY, Ruan X, Yang SG, Hao GF, Yang WC, Yang GF.. (2015) Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors., 92 [PMID:25590863 ] [10.1016/j.ejmech.2015.01.018 ]